Summary of various treatment modalities utilized for patients with COVID-19 infection complicated with aortic thrombus and overall outcomes
| Treatment modality | Favorable outcome | Unknown outcome | Mortality |
|---|---|---|---|
| Anticoagulation only (n = 14, 32.5%) | 57% (n = 8) | 7% (n = 1) | 35% (n = 5) |
| Anticoagulation with antiplatelet therapy (n = 3, 6.9%) | 100% (n = 3) | 0% | 0% |
| Medical management (not reported specifically) (n = 7, 16.2%) | 42% (n = 3) | 28% (n = 2) | 28% (n = 2) |
| Systemic thrombolysis (n = 2, 4.6%) | 50% (n = 1) | 50% (n = 1) | n = 0 |
| Surgical thrombectomy (n = 9, 20.9%) | 77.7% (n = 7) | n = 0 | 22.3% (n = 2) |
| Axillobifemoral bypass surgery (n = 2) | 50% (n =1) | n = 0 | 50% (n = 1) |
| Catheter directed thrombolysis (n = 2, 4.6%) | 50% (n = 1) | 50% (n = 1) | n = 0 |
| Endovascular thrombectomy (n = 1, 2.3%) | n = 0 | 100% (n = 1) | n = 0 |
| Catheter directed thrombolysis with surgical thrombectomy (n = 1, 2.3%) | 100% (n = 1) | n = 0 | n = 0 |
| Systemic thrombolysis with surgical thrombectomy (n = 1, 2.3%) | n = 0 | n = 0 | 100% (n = 1) |